Key points from article :
Acorn Biolabs, a Canadian company, raised $8 million in Series A funding to develop its stem cell cryopreservation service.
This service extracts stem cells from hair follicles for future regenerative treatments.
The company collects 50 hair follicles for stem cell extraction, a non-invasive procedure.
Hair follicles contain valuable stem cells that can be used in various medical treatments.
The extracted cells are frozen at -196°C to stop aging and preserve them for later use.
The preserved cells can be used to create personalized treatments for tissue rejuvenation, injury recovery, and combat disease.
Plans to use the funds to expand its cosmetic products and market reach.
The first topical product is expected to launch within a year.
“At the core, we facilitate the collection, expansion and storage of a patient’s own cells through our hair-follicle based cryopreservation business,” said Acorn CEO Drew Taylor.
